This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Achillea millefolium (Yarrow) is a medicinal plant used globally for its anti-inflammatory, antioxidant, and hepatoprotective properties [PMID:19075697, PMID:42282446].
Background
Yarrow is a herbaceous plant in the Asteraceae family of Greek origin [PMID:38076118, PMID:35639782]. It is one of the oldest known botanicals used by humans and is significant in the pharmaceutical field [PMID:38076118].
Traditional uses
Historically used to treat malaria, hepatitis, jaundice, liver disorders, inflammatory and spasmodic gastro-intestinal disorders, and hepato-biliary complaints [PMID:23959026, PMID:17704978]. Other traditional indications include menstrual irregularities, cramps, fever, wound healing, cough, influenza, pneumonia, kidney stones, high blood pressure, rheumatoid arthritis, gout, osteoarthritis, hemorrhagic disorders, chicken pox, cystitis, diabetes mellitus, indigestion, dyspepsia, eczema, psoriasis, and boils [PMID:23959026, PMID:19075697].
Active compounds
Bioactive components include flavonoids (kaempferol, luteolin, apigenin, chrysoeriol), sesquiterpene lactones (guaianolides such as millefoliumins and millefolactons), phenolic acids (caffeoylquinic acids, chlorogenic acid), polyacetylenes, simple coumarins, and monoterpenes [PMID:11558643, PMID:28868116, PMID:33761376, PMID:36963706, PMID:38869958, PMID:32722270, PMID:32325741].
Mechanism of action
Anti-inflammatory effects are mediated through the inhibition of nitric oxide (NO) release and repression of pro-inflammatory cytokines such as TNF-α and IL-6 [PMID:36963706, PMID:37839587, PMID:38869958]. It may modulate signaling pathways including NF-κB, PI3K/AKT/mTOR, and RAS/RAF [PMID:42282446]. Antispasmodic properties are mediated by flavonoids, while choleretic effects are caused by dicaffeoylquinic acids [PMID:17704978]. Gastroprotective actions against ethanol-induced ulcers are linked to the Nrf2/HO-1 pathway [PMID:36432009].
Clinical evidence
Evidence CAnxiety
Showed promising effects in animal models [PMID:33480339]
Evidence DLocalized Bleeding
Hydroalcoholic extract significantly reduced bleeding time in rat liver models [PMID:38283274]
Evidence DDoxorubicin-induced renal injury
Ameliorated injury via inhibition of oxidative stress and inflammation in rats [PMID:39734352]
Evidence DCisplatin-induced ocular toxicity
Evaluated for biochemical and histopathological effects in rats [PMID:34180746]
Evidence DGastrointestinal Spasms
Hydroalcoholic extract showed antispasmodic effects in the isolated ileum of rats [PMID:24311877]
Safety & adverse effects
Generally considered safe for supplemental use [PMID:23959026, PMID:28868116]. However, guinea pigs were sensitized to crude extracts of the whole plant and flowers [PMID:11558643]. Yarrow tea showed weak genotoxicity in a Drosophila melanogaster test [PMID:11558643]. In cosmetics, concerns were raised regarding components like linalool, thujone, quercetin, hydroquinone, or α-peroxyachifolid [PMID:27913788].
Drug interactions
May interact with hormonal, antibiotic, and anticancer drugs, potentially altering concentrations of drugs such as Erythromycin, Diazepam, and Cyclosporine by affecting Cytochromes P450 metabolism enzymes [PMID:38076118].
Evidence summary
The evidence is primarily based on review articles and animal/in vitro studies (Levels C and D). While traditional use is extensive and some pharmacological activities (anti-inflammatory, antioxidant) are supported by experimental data, human clinical trials are rare.
PubMed sources
1.PMID: 33480339 (2022) — Anti-anxiety Properties of Selected Medicinal Plants. · Current pharmaceutical biotechnology
2.PMID: 38076118 (2023) — Achillea millefolium: Mechanism of action, pharmacokinetic, clinical drug-drug interactions and tolerability. · Heliyon
3.PMID: 11558643 (2001) — Final report on the safety assessment of Yarrow (Achillea millefolium) Extract. · International journal of toxicology
4.PMID: 23959026 (2013) — Minireview on Achillea millefolium Linn. · The Journal of membrane biology
5.PMID: 27913788 (2016) — Safety Assessment of Achillea millefolium as Used in Cosmetics. · International journal of toxicology
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 35639782 (2023) — Investigation on anti-Corona viral potential of Yarrow tea. · Journal of biomolecular structure & dynamics
7.PMID: 33820524 (2022) — Traditionally Used Natural Products in Preventing Ionizing Radiation-Induced. · Anti-cancer agents in medicinal chemistry
8.PMID: 36713795 (2022) — Aqueous extract of Achillea millefolium significantly affects mesenchymal stem cell renewal and differentiation in a dose dependent manner. · Journal of stem cells & regenerative medicine
9.PMID: 33761376 (2021) — Guaianolide sesquiterpene lactones from Achillea millefolium L. · Phytochemistry
10.PMID: 17704978 (2007) — Achillea millefolium L. s.l. revisited: recent findings confirm the traditional use. · Wiener medizinische Wochenschrift (1946)
11.PMID: 19075697 (2008) — Biological activities of yarrow species (Achillea spp.). · Current pharmaceutical design
12.PMID: 36432009 (2022) — Achillea millefolium Essential Oil Mitigates Peptic Ulcer in Rats through Nrf2/HO-1 Pathway. · Molecules (Basel, Switzerland)
13.PMID: 36914847 (2023) — Germacrane-Type Sesquiterpene Lactones from Achillea millefolium L. and Their Anti-Inflammatory Activity. · Chemistry & biodiversity
14.PMID: 32722270 (2020) — Achillea millefolium L. and Achillea biebersteinii Afan. Hydroglycolic Extracts-Bioactive Ingredients for Cosmetic Use. · Molecules (Basel, Switzerland)
15.PMID: 36963706 (2023) — Guaianolides from Achillea millefolium L. and their anti-inflammatory activity. · Phytochemistry
16.PMID: 30424560 (2018) — The Phytochemistry of Cherokee Aromatic Medicinal Plants. · Medicines (Basel, Switzerland)
17.PMID: 42282446 (2026) — Exploring the Nutraceutical Potential of Achillea millefolium L.: Phytochemical Composition, Biological Activities, and Industrial Applications. · Food science & nutrition
18.PMID: 28868116 (2017) — Bio-effectiveness of the main flavonoids of Achillea millefolium in the pathophysiology of neurodegenerative disorders- a review. · Iranian journal of basic medical sciences
19.PMID: 39734352 (2024) — Achillea millefolium ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation in rats. · Turkish journal of medical sciences
20.PMID: 32325741 (2020) — Valorization of Yarrow (Achillea millefolium L.) By-Product through Application of Subcritical Water Extraction. · Molecules (Basel, Switzerland)
21.PMID: 34180746 (2021) — Effects of Achillea millefolium on cisplatin induced ocular toxicity: an experimental study. · Cutaneous and ocular toxicology
22.PMID: 24311877 (2013) — Antispasmodic effects of yarrow (Achillea millefolium L.) extract in the isolated ileum of rat. · African journal of traditional, complementary, and alternative medicines : AJTCAM
23.PMID: 38869958 (2024) — Chemical Composition of Achillea millefolium L. and Their Anti-Inflammatory Activity. · Chemistry & biodiversity
24.PMID: 37839587 (2023) — Guaianolide-type sesquiterpene lactones from Achillea millefolium L. and their anti-inflammatory activity. · Phytochemistry
25.PMID: 41391266 (2026) — Phytochemicals from Achillea millefolium target NAFLD and NASH: A network pharmacology integrated bioinformatics and molecular docking investigation. · Computational biology and chemistry
26.PMID: 33833853 (2021) — Achillea Species as Sources of Active Phytochemicals for Dermatological and Cosmetic Applications. · Oxidative medicine and cellular longevity
27.PMID: 38576446 (2024) — Novel bioactive extract from yarrow obtained by the supercritical antisolvent-assisted technique inhibits lipid metabolism in colorectal cancer. · Frontiers in bioengineering and biotechnology
28.PMID: 38283274 (2024) — Safety and hemostatic effect of Achillea millefolium L. in localized bleeding. · Hepatology forum